![Carmit Nadri-Shay](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Carmit Nadri-Shay is currently working as Vice President-Regulatory Affairs at Old Ayala, Inc. and Ayala Pharmaceuticals, Inc. He previously worked as Director-Regulatory Affairs at Kamada Ltd. and Senior Manager-Regulatory Affairs at Protalix Biotherapeutics Ltd. He holds a doctorate degree from Ben-Gurion University of the Negev.
| Sociétés | Poste | Début |
|---|---|---|
| ADVAXIS, INC. | Conseiller Juridique Général | - |
| Sociétés | Poste | Fin |
|---|---|---|
Protalix Biotherapeutics Ltd.
 Protalix Biotherapeutics Ltd. BiotechnologyHealth Technology Developes a proprietary plant cell culture technology and innovative bioreactor system | Conseiller Juridique Général | - |
| AYALA PHARMACEUTICALS, INC. | Conseiller Juridique Général | - |
| KAMADA LTD. | Conseiller Juridique Général | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 5 |
|---|---|
Ben-Gurion University of the Negev
 Ben-Gurion University of the Negev Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Protalix Biotherapeutics Ltd.
Protalix Biotherapeutics Ltd. BiotechnologyHealth Technology Developes a proprietary plant cell culture technology and innovative bioreactor system | Health Technology |
Kamada Ltd.
 Kamada Ltd. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops and manufactures plasma-derived therapeutics products | Health Technology |
Old Ayala, Inc.
 Old Ayala, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage oncology company which develops cancer therapies | Health Technology |
Ayala Pharmaceuticals, Inc.
 Ayala Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company that develops cancer therapeutics | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
